Drug Trial Radar · NCT01403116
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Last checked: Nov 19, 2026Latest source record: Aug 14, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
325
Actual
Start
Jul 2011
Primary completion
Sep 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- Clarus Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- PharmaNet; Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- First posted
- Jul 27, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Male only, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the safety and efficacy of an oral testosterone undecanoate formulation for use as testosterone-replacement therapy in men with low testosterone.
Conditions
- Male Hypogonadism
Interventions
Oral testosterone undecanoateDrug
Starting dose: 200 mg T (as TU) BID. Doses may be titrated up to a maximum dose of 300 mg T (as TU) BID or down to a minimum dose of 100 mg T (as TU) BID based on serum T values collected at 4-6 hours post AM dose on Days 30 and 60.
topical testosterone gelDrug
Starting dose: 5 g T applied once daily. Doses may be titrated up to a maximum dose of 10 g daily or down to a minimum dose of 2.5 g daily based on serum T values collected at 4-6 hours post AM dose on Days 30 and 60.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Treated Patients With Average Serum Testosterone (T) Concentrations (Cavg) Between 300 and 1000 ng/dLTime frame: Following 90 days of treatment
Locations
30 sites in 2 countries. Site status is shown where the registry gives one.
Alabama Clinical Therapeutics, Inc.
Birmingham, Alabama
Alabama Internal Medicine, PC
Birmingham, Alabama
Alabama Clinical Therapeutics
Calera, Alabama
Medical Affliated Research Center, Inc.
Huntsville, Alabama
Quality of Life Medical and Research Centers, LLC
Tucson, Arizona
Providence Clinical Research
Burbank, California
South Orange County Endocrinology
Laguna Hills, California
Tower Urology
Los Angeles, California
David Geffen School of Medicine
Los Angeles, California
Harbor-UCLA Medical Center, LA Biomedical Research Institute
Torrance, California
Connecticut Clinical Research Center/ConnecTrials
Middlebury, Connecticut
University of CT School of Medicine
New Haven, Connecticut
South Florida Medical Research
Aventura, Florida
University of Louisville
Louisville, Kentucky
Johns Hopkins University
Baltimore, Maryland
Boston University School of Medicine
Boston, Massachusetts
Maimonides Medical Center
Brooklyn, New York
Bruce R. Gilbert, MD, PhD
Great Neck, New York
University Urology Associates
New York, New York
Michael A. Werner, MD, PC
Purchase, New York
Sunstone Medical Research
Medford, Oregon
Urologic Consultants of Southeast Pennsylvania
Bala-Cynwyd, Pennsylvania
Research Across America
Carrollton, Texas
Research Across America
Dallas, Texas
University of Washington
Seattle, Washington
University of Bonn, Clinic for Dermatology and Allergy
Bonn, Germany
University of Halle, Center for Reproduction and Androlgoy
Halle, Germany
Praxis Dr. Szymula
Leipzig, Germany
Praxis Dr. Schulze
Markkleeberg, Germany
University of Muenster, Center for Reproduction and Andrology
Münster, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.